These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4326475)

  • 1. [Toxins and anatoxins of Clostridium perfringens].
    Cherkas GP; Kalinichenko MF; Biriukova SV; Podgornaia LG
    Mikrobiol Zh; 1971; 33(2):173-5. PubMed ID: 4326475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conditions of formation of anatoxins of Clostridium perfringens, Cl. Oedematiens and Cl. septicum from toxins obtained in casein media].
    Nechaevskaia MR; Cherkas GP; Kalinichenko NF; Berezhkovskaia LIa; Biriukova SV; Podgornaia LG; Mukhina AA; Polchenko OT; Leĭbova IM; Konik VIa
    Mikrobiol Zh; 1966; 28(4):56-61. PubMed ID: 4297878
    [No Abstract]   [Full Text] [Related]  

  • 3. [Isolation of purified Cl. oedematiens toxoids from concentrated toxins using casein nutrient media].
    Nenashev VP; Artemenko VD
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Jan; 48(1):87-90. PubMed ID: 5553632
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the antigenic structure of anatoxins of Clostridium perfringens, Cl. oedematiens, Cl. septicum and Cl. tetani by determining their fixation properties].
    Kalinichenko NF
    Mikrobiol Zh; 1966; 28(4):75-7. PubMed ID: 4297189
    [No Abstract]   [Full Text] [Related]  

  • 5. [The fractional composition of the toxins and anatoxins of Cl. oedematiens. I. Fractionation of the toxins and anatoxins by the gel filtration method].
    Kulak VG; Golshmid VK; Nenashev VP; Glushkova AI; Ianishevskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Jun; 47(6):112-5. PubMed ID: 5495122
    [No Abstract]   [Full Text] [Related]  

  • 6. [Standardization of the control technics of Clostridium perfringens vaccine. Use of a reference vaccine].
    Bousicaux A
    Dev Biol Stand; 1976; 32():45-61. PubMed ID: 187511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Composition of nutrient media and toxin formation of Clostridium perfringens].
    Urguev KR
    Veterinariia; 1974 Mar; 3(0):46-7. PubMed ID: 4365136
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha toxoid of Clostridium perfringens. I. Purification and toxoiding of alpha toxin of C. perfringens.
    Ito A
    Jpn J Med Sci Biol; 1968 Dec; 21(6):379-91. PubMed ID: 4306752
    [No Abstract]   [Full Text] [Related]  

  • 9. The International Reference Preparations of Clostridium welchii (C. perfringens) beta and epsilon toxoids.
    Davidson I; Gray AK; Hebert CN; Lesslie IW
    Bull World Health Organ; 1978; 56(4):641-8. PubMed ID: 215337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxin formation by Cl. perfringens on a casein-pancreatic medium].
    Urguev KR; Kirillov LV; Liubich FD; Lavchenko EG; Panfilov ID
    Veterinariia; 1973 Feb; 49(2):39-40. PubMed ID: 4356903
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxin formation by Cl. perfringens type E].
    Zemlianitskaia EP; Matveev KI; Tsurikov FF
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):86-90. PubMed ID: 4307060
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of anaerobic infections of ruminants in Madagascar by intradermal administration of ultrafiltered toxoids of locally specific clostridia].
    Seifert HS; Böhnel H; Ranaivoson A
    Dtsch Tierarztl Wochenschr; 1983 Jul; 90(7):274-9. PubMed ID: 6311508
    [No Abstract]   [Full Text] [Related]  

  • 13. Sedimentation of bacteria with polyethylene glycol.
    Cameron CM; Weiss KE
    Onderstepoort J Vet Res; 1974 Jun; 41(2):75-8. PubMed ID: 4375273
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the antigenic composition of Cl. perfringens toxin and anatoxins].
    ISPOLATOVSKAIA MV; MARMALEVSKAIA LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():87-93. PubMed ID: 13718052
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification of beta-toxin of Clostridium perfringens type C.
    Akama K; Otani S; Kameyama S
    Jpn J Med Sci Biol; 1968 Dec; 21(6):423-6. PubMed ID: 4306754
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperimmunization of horses with alpha toxoid of Clostridium perfringens.
    Yanamoto A; Ito A; Murata R; Uematsu N; Nagai K
    Jpn J Med Sci Biol; 1970 Apr; 23(2):111-5. PubMed ID: 4318177
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunogenic properties of Cl. perfringens anatoxins obtained from purified toxins].
    Dmitrieva LN; Shemanova GF; Akhundova KA; Vlasova EV; Il'nitskaia KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Nov; (11):134-6. PubMed ID: 176848
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neuraminidase in the cells and toxins of Cl. perfringens].
    Ispolatovskaia MV; Tokinova TN; Cherikovskaia EN; Borishpolets ZI
    Vopr Med Khim; 1973; 19(1):49-54. PubMed ID: 4362796
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the study of the toxico-infective properties of Cl. perfringens].
    Khazanova VV
    Lab Delo; 1969; 3():164-7. PubMed ID: 4185182
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification of Clostridium toxoids.
    Buchowicz I; Hay M; Schiller B; Korbecki M; Sochańska R
    Acta Microbiol Pol; 1977; 26(3):285-94. PubMed ID: 70974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.